Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker KVYO
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Summit Partners Co-Invest (Kiwi), LP Owner | KVYO Klaviyo, Inc. | 182,210 | $3.8M | — | Nov 9, 2026 | — | Form 144 ↗ |
| Nov 9, 2026 | Summit Investors Ge IX/VC IV, LLC Owner | KVYO Klaviyo, Inc. | 15,531 | $323.4K | — | Nov 9, 2026 | — | Form 144 ↗ |
| Nov 9, 2026 | Summit Partners Growth Equity Fund IX-B, L.P. Owner | KVYO Klaviyo, Inc. | 1.71M | $35.6M | — | Nov 9, 2026 | — | Form 144 ↗ |
| Nov 9, 2026 | Summit Partners Growth Equity Fund IX-A, L.P. Owner | KVYO Klaviyo, Inc. | 2.74M | $57.1M | — | Nov 9, 2026 | — | Form 144 ↗ |
| Nov 9, 2026 | Summit Investors Ge IX/VC IV (UK), L.P. Owner | KVYO Klaviyo, Inc. | 2,016 | $42.0K | — | Nov 9, 2026 | — | Form 144 ↗ |
| Nov 6, 2026 amended | Roxanne Oulman Director | KVYO Klaviyo, Inc. | 13,989 | $284.8K | 10b5-1 | Nov 6, 2026 | Form 4 ↗ 3 days later · 13,989 shares | Form 144/A ↗ |
| Nov 6, 2026 | Roxanne Oulman Director | KVYO Klaviyo, Inc. | 13,989 | $284.8K | 10b5-1 | Nov 6, 2026 | Form 4 ↗ 3 days later · 13,989 shares | Form 144 ↗ |
| Nov 5, 2026 | Ed Hallen Officer, Director | KVYO Klaviyo, Inc. | 98,782 | $2.0M | 10b5-1 | Nov 5, 2026 | Form 4 ↗ 4 days later · 98,782 shares | Form 144 ↗ |
| Oct 7, 2026 | Ed Hallen Officer, Director | KVYO Klaviyo, Inc. | 97,482 | $1.7M | 10b5-1 | Oct 7, 2026 | Form 4 ↗ 33 days later · 98,782 shares | Form 144 ↗ |
| Sep 24, 2026 | Ed Hallen Officer, Director | KVYO Klaviyo, Inc. | 1,300 | $22.1K | 10b5-1 | Sep 24, 2026 | Form 4 ↗ 1 day later · 1,300 shares | Form 144 ↗ |
| Sep 17, 2026 | Amanda Whalen Officer | KVYO Klaviyo, Inc. | 42,000 | $681.7K | 10b5-1 | Sep 17, 2026 | — | Form 144 ↗ |
| Sep 11, 2026 | Susan St. Ledger Director | KVYO Klaviyo, Inc. | 2,328 | $37.1K | 10b5-1 | Sep 11, 2026 | Form 4 ↗ 3 days later · 2,328 shares | Form 144 ↗ |
| Aug 31, 2026 | Ed Hallen Officer, Director | KVYO Klaviyo, Inc. | 98,782 | $2.0M | 10b5-1 | Aug 31, 2026 | Form 4 ↗ 1 day later · 98,782 shares | Form 144 ↗ |
| Aug 31, 2026 | Landon Ramon Edmond Officer | KVYO Klaviyo, Inc. | 8,103 | $163.3K | 10b5-1 | Aug 31, 2026 | Form 4 ↗ 1 day later · 61,576 shares | Form 144 ↗ |
| Aug 28, 2026 | Landon Edmond Officer | KVYO Klaviyo, Inc. | 53,473 | $1.0M | 10b5-1 | Aug 28, 2026 | Form 4 ↗ 4 days later · 61,576 shares | Form 144 ↗ |
| Aug 11, 2026 | Summit Investors GE IX/VC IV (UK), L.P. 10% Stockholder | KVYO Klaviyo, Inc. | 2,016 | $37.0K | — | Aug 11, 2026 | Form 4 ↗ 2 days later · 5.00M shares | Form 144 ↗ |
| Aug 11, 2026 | Summit Partners Co-Invest (Kiwi) L.P. 10% Stockholder | KVYO Klaviyo, Inc. | 182,210 | $3.3M | — | Aug 11, 2026 | Form 4 ↗ 2 days later · 5.00M shares | Form 144 ↗ |
| Aug 11, 2026 | Summit Investors GE IX-VC IV, LLC 10% Stockholder | KVYO Klaviyo, Inc. | 15,531 | $285.1K | — | Aug 11, 2026 | Form 4 ↗ 2 days later · 5.00M shares | Form 144 ↗ |
| Aug 11, 2026 | Summit Partners Growth Equity Fund IX-B, L.P. 10% Stockholder | KVYO Klaviyo, Inc. | 1.85M | $33.9M | — | Aug 11, 2026 | Form 4 ↗ 2 days later · 5.00M shares | Form 144 ↗ |
| Aug 11, 2026 | Summit Partners Growth Equity Fund IX-A, L.P. 10% Stockholder | KVYO Klaviyo, Inc. | 2.96M | $54.3M | — | Aug 11, 2026 | Form 4 ↗ 2 days later · 5.00M shares | Form 144 ↗ |
| Jun 18, 2026 | Amanda Whalen Officer | KVYO Klaviyo, Inc. | 42,000 | $565.3K | 10b5-1 | Jun 18, 2026 | Form 4 ↗ same day · 14,000 shares | Form 144 ↗ |
| May 26, 2026 | Andrew Bialecki Director, Officer, 10% Stockholder | KVYO Klaviyo, Inc. | 212,529 | $3.2M | 10b5-1 | May 26, 2026 | Form 4 ↗ 2 days later · 212,529 shares | Form 144 ↗ |
| May 18, 2026 | Susan St. Ledger Director | KVYO Klaviyo, Inc. | 9,334 | $133.2K | 10b5-1 | May 18, 2026 | Form 4 ↗ 2 days later · 9,334 shares | Form 144 ↗ |
| Apr 20, 2026 | Landon Ramon Edmond Officer | KVYO Klaviyo, Inc. | 9,623 | $179.7K | 10b5-1 | Apr 20, 2026 | Form 4 ↗ 2 days later · 9,623 shares | Form 144 ↗ |
| Apr 16, 2026 | Amanda Whalen Officer | KVYO Klaviyo, Inc. | 28,000 | $514.4K | 10b5-1 | Apr 16, 2026 | Form 4 ↗ 1 day later · 14,000 shares | Form 144 ↗ |
| Apr 7, 2026 | Andrew Bialecki Director, Officer, 10% Stockholder | KVYO Klaviyo, Inc. | 637,778 | $12.3M | 10b5-1 | Apr 7, 2026 | Form 4 ↗ 2 days later · 200,000 shares | Form 144 ↗ |
| Mar 17, 2026 | Stephen E. Rowland Officer | KVYO Klaviyo, Inc. | 4,940 | $94.8K | 10b5-1 | Mar 17, 2026 | — | Form 144 ↗ |
| Mar 12, 2026 | Landon Ramon Edmond Officer | KVYO Klaviyo, Inc. | 14,366 | $285.3K | 10b5-1 | Mar 12, 2026 | Form 4 ↗ 1 day later · 14,366 shares | Form 144 ↗ |
| Mar 5, 2026 | Stephen E. Rowland Officer | KVYO Klaviyo, Inc. | 4,940 | $96.5K | 10b5-1 | Mar 5, 2026 | — | Form 144 ↗ |
| Feb 24, 2026 | Andrew Bialecki Director, Officer, 10% Stockholder | KVYO Klaviyo, Inc. | 1.35M | $21.4M | 10b5-1 | Feb 24, 2026 | Form 4 ↗ 2 days later · 200,000 shares | Form 144 ↗ |
| Dec 18, 2025 | Landon Ramon Edmond Officer | KVYO Klaviyo, Inc. | 39,283 | $1.2M | 10b5-1 | Dec 18, 2025 | Form 4 ↗ 1 day later · 14,190 shares | Form 144 ↗ |
| Dec 18, 2025 | Amanda Whalen Officer | KVYO Klaviyo, Inc. | 56,000 | $1.7M | 10b5-1 | Dec 18, 2025 | Form 4 ↗ 1 day later · 14,000 shares | Form 144 ↗ |
| Dec 17, 2025 | Ed Hallen Officer, Director | KVYO Klaviyo, Inc. | 117,550 | $3.6M | 10b5-1 | Dec 17, 2025 | Form 4 ↗ 2 days later · 117,550 shares | Form 144 ↗ |
| Dec 15, 2025 | Ed Hallen Officer, Director | KVYO Klaviyo, Inc. | 757 | $22.8K | 10b5-1 | Dec 15, 2025 | Form 4 ↗ 2 days later · 757 shares | Form 144 ↗ |
| Dec 15, 2025 | Stephen Rowland Officer | KVYO Klaviyo, Inc. | 14,208 | $424.0K | 10b5-1 | Dec 15, 2025 | Form 4 ↗ 2 days later · 7,104 shares | Form 144 ↗ |
| Dec 2, 2025 | Andrew Bialecki Director, Officer, 10% Stockholder | KVYO Klaviyo, Inc. | 1.35M | $38.0M | 10b5-1 | Dec 2, 2025 | Form 4 ↗ 2 days later · 142,997 shares | Form 144 ↗ |
| Nov 20, 2025 | Landon Ramon Edmond Officer | KVYO Klaviyo, Inc. | 14,394 | $396.4K | 10b5-1 | Nov 20, 2025 | Form 4 ↗ 1 day later · 14,394 shares | Form 144 ↗ |
| Nov 17, 2025 | Galvin Carmel Officer | KVYO Klaviyo, Inc. | 11,156 | $319.3K | 10b5-1 | Nov 17, 2025 | Form 4 ↗ 1 day later · 11,156 shares | Form 144 ↗ |
| Nov 17, 2025 | Stephen Rowland Officer | KVYO Klaviyo, Inc. | 7,104 | $203.2K | 10b5-1 | Nov 17, 2025 | Form 4 ↗ 1 day later · 7,104 shares | Form 144 ↗ |
| Nov 14, 2025 | Amanda Whalen Officer | KVYO Klaviyo, Inc. | 15,000 | $427.2K | 10b5-1 | Nov 14, 2025 | Form 4 ↗ 4 days later · 15,000 shares | Form 144 ↗ |
| Nov 12, 2025 | Ed Hallen Officer, Director | KVYO Klaviyo, Inc. | 2,811 | $84.3K | 10b5-1 | Nov 11, 2025 | Form 4 ↗ 35 days later · 757 shares | Form 144 ↗ |
| Nov 10, 2025 | Ed Hallen Officer, Director | KVYO Klaviyo, Inc. | 59,492 | $1.8M | 10b5-1 | Nov 10, 2025 | Form 4 ↗ 2 days later · 62,303 shares | Form 144 ↗ |
| Oct 15, 2025 | Stephen Rowland Officer | KVYO Klaviyo, Inc. | 7,105 | $173.6K | 10b5-1 | Oct 15, 2025 | Form 4 ↗ 1 day later · 7,105 shares | Form 144 ↗ |
| Sep 15, 2025 | Ed Hallen Officer, Director | KVYO Klaviyo, Inc. | 89,748 | $2.8M | 10b5-1 | Sep 15, 2025 | Form 4 ↗ 2 days later · 89,748 shares | Form 144 ↗ |
| Sep 15, 2025 | Stephen Rowland Officer | KVYO Klaviyo, Inc. | 7,105 | $221.6K | 10b5-1 | Sep 15, 2025 | Form 4 ↗ 2 days later · 7,105 shares | Form 144 ↗ |
| Sep 10, 2025 | Susan St. Ledger Director | KVYO Klaviyo, Inc. | 3,413 | $109.9K | 10b5-1 | Sep 10, 2025 | Form 4 ↗ 2 days later · 3,413 shares | Form 144 ↗ |
| Sep 8, 2025 | Summit Investors Ge IX/VC IV (UK), L.P. 10% Stockholder | KVYO Klaviyo, Inc. | 1,613 | $53.6K | — | Sep 8, 2025 | Form 4 ↗ 2 days later · 4.00M shares | Form 144 ↗ |
| Sep 8, 2025 | Summit Investors Ge IX/VC IV, LLC Owner | KVYO Klaviyo, Inc. | 12,425 | $412.5K | — | Sep 8, 2025 | Form 4 ↗ 2 days later · 4.00M shares | Form 144 ↗ |
| Sep 8, 2025 | Summit Partners Co-Invest (Kiwi), LP Owner | KVYO Klaviyo, Inc. | 145,768 | $4.8M | — | Sep 8, 2025 | Form 4 ↗ 2 days later · 4.00M shares | Form 144 ↗ |
| Sep 8, 2025 | Summit Partners Growth Equity Fund IX-B, L.P. 10% Stockholder | KVYO Klaviyo, Inc. | 1.48M | $49.0M | — | Sep 8, 2025 | Form 4 ↗ 2 days later · 4.00M shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:43 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances